J&J ordered to pay $846 million for role in opioid crisis

The pharmaceutical company says it will appeal the judgement A judge has fined drug manufacturer Johnson & Johnson and its pharmaceutical subsidiary Janssen US$572 million (AUD$846 million) after finding the company breached the state’s public nuisance law in promoting opioid products while downplaying their risks and overstating their efficacy. Judge Thad Balkman of the Cleveland